(Q40288346)

19 September 2017

title

Phosphorylation of the HTLV-1 matrix L-domain-containing protein by virus-associated ERK-2 kinase (English)

1 reference

Human T-lymphotropic virus 1

19 September 2017

1 reference

1 reference

7

1 reference

19 September 2017

6

Christian Devaux

1 reference

19 September 2017

Bénédicte Hémonnot

1

1 reference

19 September 2017

Dorothée Molle

2

1 reference

19 September 2017

Martine Bardy

3

1 reference

19 September 2017

Bernard Gay

4

1 reference

19 September 2017

Daniel Laune

5

1 reference

19 September 2017

language of work or name

English

0 references

publication date

25 April 2006

1 reference

19 September 2017

1 reference

19 September 2017

volume

349

1 reference

19 September 2017

issue

2

1 reference

19 September 2017

page(s)

430-439

1 reference

Nedd4.1-mediated ubiquitination and subsequent recruitment of Tsg101 ensure HTLV-1 Gag trafficking towards the multivesicular body pathway prior to virus budding

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.043

PPPYEPTAP Motif Is the Late Domain of Human T-Cell Leukemia Virus Type 1 Gag and Mediates Its Functional Interaction with Cellular Proteins Nedd4 and Tsg101

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.043

Polypeptides of Mason-Pfizer monkey virus. I. Synthesis and processing of the gag-gene products

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.043

Active cAMP-dependent protein kinase incorporated within highly purified HIV-1 particles is required for viral infectivity and interacts with viral capsid protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.043

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.043

The host cell MAP kinase ERK-2 regulates viral assembly and release by phosphorylating the p6gag protein of HIV-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.043

Gettin' down with ubiquitin: turning off cell-surface receptors, transporters and channels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.043

Virion-associated protein kinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.043

Modulation of HIV-1 infectivity by MAPK, a virion-associated kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.043

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.043

The PPPY motif of human T-cell leukemia virus type 1 Gag protein is required early in the budding process

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.043

Function of WW domains as phosphoserine- or phosphothreonine-binding modules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.043

Role of ESCRT-I in retroviral budding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.043

The splicing factor, Prp40, binds the phosphorylated carboxyl-terminal domain of RNA polymerase II.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.043

Phospho-carboxyl-terminal domain binding and the role of a prolyl isomerase in pre-mRNA 3'-End formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.043

The late-domain-containing protein p6 is the predominant phosphoprotein of human immunodeficiency virus type 1 particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.043

Actin-binding cellular proteins inside human immunodeficiency virus type 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.043

Equine infectious anemia virus and the ubiquitin-proteasome system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.043

Ubiquitin is part of the retrovirus budding machinery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.043

Proteasome inhibition interferes with gag polyprotein processing, release, and maturation of HIV-1 and HIV-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.043

Specific binding of the type C viral core protein p12 with purified viral RNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.043

Phosphorylation of murine type C viral p12 proteins regulates their extent of binding to the homologous viral RNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.043

A role for ubiquitin ligase recruitment in retrovirus release

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.043

AIP1/ALIX Is a Binding Partner for HIV-1 p6 and EIAV p9 Functioning in Virus Budding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.043

NeW wrinkles for an old domain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.043

Structural basis for phosphoserine-proline recognition by group IV WW domains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.043

Ubiquitin in retrovirus assembly: actor or bystander?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.043

Both the PPPY and PTAP motifs are involved in human T-cell leukemia virus type 1 particle release

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.043

In vitro phosphorylation of murine leukemia virus proteins: specific phosphorylation of Pr65gag, the precursor of the internal core antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.043

Infectivity of Moloney murine leukemia virus defective in late assembly events is restored by late assembly domains of other retroviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.043

Phosphorylated serine residues and an arginine-rich domain of the moloney murine leukemia virus p12 protein are required for early events of viral infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.043

Association of ERK2 mitogen-activated protein kinase with human immunodeficiency virus particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.043

Virions released from cells transfected with a molecular clone of human T-cell leukemia virus type I give rise to primary and secondary infections of T cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.043

7 January 2021

Particle size determinants in the human immunodeficiency virus type 1 Gag protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.043

7 January 2021

Characterization of 40,000- and 25,000-dalton intermediate precursors to Rauscher murine leukemia virus gag gene products

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.043

7 January 2021

Ubiquitin is covalently attached to the p6Gag proteins of human immunodeficiency virus type 1 and simian immunodeficiency virus and to the p12Gag protein of Moloney murine leukemia virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.043

7 January 2021

10.1016/J.VIROL.2006.02.043

Identifiers

DOI

1 reference

19 September 2017

1 reference